Can't wait for AristotleI saw Exas science in 2016 at 6$ and now they are trading at 128. Wont miss my chance with szls with a market cap of 21B (Exas) im sure szls can do better in few years. Aristotle only need to be adopt by physicians and insurances. With the covid-19 they are already operating the lab so this eliminates a large part of the risk. Hope Aristotle will be launch with collaboration of large health care group. If so this stock is going to the moon. Patience is the key $$$ finger cross.